News | August 13, 2021
Aurobindo Pharma buys Cronus Pharma Specialities for Rs 420 crores
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
Substantial reduction in losses
The healthcare vertical is US-focused, has 35-plus clients and 24,000 employees across 34 locations in five countries
This deal makes Meddo, one of the largest health-tech players in India
Drug formulations and biologics make impressive gains
The company is confident of commencing production at both Mahad and Chiplun units soon
The company has reported PAT of Rs. 10.7 crore for Q1 FY22, higher by 23% YoY
The shareholders have also ratified the Board’s approval to allot 10 lakhs warrants to the Promoter, Managing Director and CEO, Mark Saldanha at the said price of Rs. 74 per warrant
The company recorded revenue of Rs 528crore as compared to Rs 444 crore, registering a growth of 19% over the corresponding quarter ended 31st March 2020
Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines
Subscribe To Our Newsletter & Stay Updated
